Clinical Trials Logo

Total Fluid Volume Increased clinical trials

View clinical trials related to Total Fluid Volume Increased.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02361736 Recruiting - Clinical trials for Total Fluid Volume Increased

Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery

Start date: March 2015
Phase: N/A
Study type: Interventional

Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be nephrotoxic as seen in studies in patients with sepsis. The investigators hypothesized that the possible nephrotoxicity of 6% HES 130/0.4 could be revealed by measurements of urinary and plasma neutrophil gelatinase-associated lipocalin and interleukin-18 (IL-18) in old patients with normal renal function during orthopaedic surgery.